Department of Pediatrics, Section of Hematology/Oncology/Bone Marrow Transplantation and the Mountain States Regional Hemophilia and Thrombosis Center, Univ of Colorado Denver and The Children’s Hospital, Aurora, CO 80045, USA.
Haematologica. 2010 Nov;95(11):1952-9. doi: 10.3324/haematol.2010.026989. Epub 2010 Jun 30.
Post-thrombotic syndrome is a manifestation of chronic venous insufficiency following deep venous thrombosis. This systematic review was conducted to critically evaluate pediatric evidence on frequency of occurrence, validity of outcome measures, and prognostic indicators of post-thrombotic syndrome.
A comprehensive literature search of original reports revealed 19 eligible studies, totaling 977 patients with upper/lower extremity deep venous thrombosis. Calculated weighted mean frequency of post-thrombotic syndrome was 26% (95% confidence interval: 23-28%) overall, and differed significantly by prospective/non-prospective analysis and use/non-use of a standardized outcome measure.
Standardized post-thrombotic syndrome outcome measures included an adaptation of the Villalta scale, the Clinical-Etiologic-Anatomic-Pathologic classification, and the Manco-Johnson instrument. Data on validity were reported only for the Manco-Johnson instrument. No publications on post-thrombotic syndrome-related quality of life outcomes were identified. Candidate prognostic factors for post-thrombotic syndrome in prospective studies included use/non-use of thrombolysis and plasma levels of factor VIII activity and D-dimer.
Given that affected children must endure chronic sequelae for many decades, it is imperative that future collaborative pediatric prospective cohort studies and trials assess as key objectives and outcomes the incidence, severity, prognostic indicators, and health impact of post-thrombotic syndrome, using validated measures.
血栓后综合征是深静脉血栓形成后慢性静脉功能不全的表现。本系统评价旨在批判性评估儿科关于血栓后综合征发生率、结局测量有效性和预后指标的证据。
全面检索原始报告,共发现 19 项符合条件的研究,总计 977 例上下肢深静脉血栓形成患者。计算出的血栓后综合征加权平均发生率为 26%(95%置信区间:23%-28%),总体上存在显著差异,差异来自前瞻性/非前瞻性分析以及是否使用标准化结局测量。
标准化的血栓后综合征结局测量包括 Villalta 量表的改编、临床病因解剖病理分类和 Manco-Johnson 仪器。仅对 Manco-Johnson 仪器报告了有效性数据。未发现关于血栓后综合征相关生活质量结局的出版物。前瞻性研究中血栓后综合征的候选预后因素包括溶栓的使用/不使用以及因子 VIII 活性和 D-二聚体的血浆水平。
鉴于受影响的儿童必须忍受数十年的慢性后遗症,未来的协作儿科前瞻性队列研究和试验必须使用经过验证的措施评估血栓后综合征的发生率、严重程度、预后指标和健康影响作为关键目标和结局。